BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Mylan Inc. 

1500 Corporate Drive

Canonsburg  Pennsylvania  15317  U.S.A.
Phone: 724-514-1800 Fax: n/a


SEARCH JOBS




Industry
Pharmaceutical






 Company News
Mylan Inc. (MYL) Commences Phase 3 Clinical Trials For Its Generic Version Of Advair Diskus® And Insulin Analog To Lantus® 9/16/2014 8:08:57 AM
Mylan Inc. (MYL) Signs Agreement With Gilead Sciences, Inc. (GILD) To Accelerate Access To Hepatitis C Treatments, Sovaldi® (Sofosbuvir) And Single Tablet Regimen Of Ledipasvir/Sofosbuvir, in Developing Countries 9/15/2014 8:39:58 AM
Mylan Inc. (MYL) Scoops Up Injectable Arixtra For $300 Million From Aspen Global Inc. 9/10/2014 6:58:39 AM
Court Grants Summary Judgment In Favor Of Mylan Inc. (MYL) And FDA Related To Generic Precedex™ 9/8/2014 8:41:46 AM
Venus Remedies Ties It Up With Mylan Inc. (MYL) For Marketing Meropenem In Three European Countries 9/8/2014 6:14:02 AM
Mylan Inc. (MYL) Launches Generic Boniva® Injection 9/5/2014 10:37:51 AM
Mylan Inc. (MYL)'s ANDA For Three Times Per Week Generic Copaxone® 40 Mg/Ml Accepted For Filing By FDA 8/28/2014 11:17:02 AM
Mylan Inc. (MYL) Launches First Generic Klor-Con® Extended-Release Tablets 8/22/2014 7:15:20 AM
Mylan Inc. (MYL) Makes Second Round Of Bidding For GlaxoSmithKline (GSK) Drug Portfolio 8/21/2014 6:08:05 AM
Mylan Inc. (MYL) Launches Generic Precedex™ Injection - Another Key Product Approval 8/19/2014 10:06:19 AM
12345678910...